Interferon- alpha and - beta restrict polyomavirus JC replication in primary human fetal glial cells: implications

Juliene K G Co1, Saguna Verma, Ulziijargal Gurjav

  • 1Retrovirology Research Laboratory, Department of Tropical Medicine, Medical Microbiology and Pharmacology, Asia-Pacific Institute of Tropical Medicine and Infectious Diseases, John A. Burns School of Medicine, Honolulu, HI 96813, USA.

Insights

Highly active antiretroviral therapy cannot stop JC polyomavirus (JCV) replication, which causes progressive multifocal leukoencephalopathy (PML). Interferon (IFN) inhibits JCV replication, suggesting intrathecal IFN as a potential adjunctive therapy for PML.

Area of Science:

  • Neurovirology
  • Immunology
  • Antiviral Therapy

Background:

  • Highly active antiretroviral therapy (HAART) is ineffective against JC polyomavirus (JCV) replication.
  • JCV causes progressive multifocal leukoencephalopathy (PML), an AIDS-defining illness.
  • Previous studies showed JCV induces interferon-stimulated genes (ISGs).

Purpose of the Study:

  • To identify viral events triggering ISG induction by JCV.
  • To evaluate type I interferon's antiviral effects on JCV replication in human fetal glial cells.
  • To assess the potential of interferon as an adjunctive therapy for PML.

Main Methods:

  • Characterization of specific JCV replication steps inducing ISGs.
  • Treatment of human fetal glial cells with type I interferons (IFNs) during JCV infection.
  • Neutralization of IFN activity with specific antibodies to assess its antiviral role.

Main Results:

  • Productive JCV replication is essential for inducing the antiviral host response (ISGs).
  • Type I IFN significantly inhibited JCV replication across all viral life cycle stages.
  • Neutralizing anti-IFN antibodies restored JCV replication, confirming IFN's direct antiviral effect.

Conclusions:

  • JCV replication is susceptible to type I IFN-mediated inhibition.
  • Interferon demonstrates potential as an adjunctive therapy for progressive multifocal leukoencephalopathy (PML).
  • Intrathecal administration of IFN is recommended due to its inability to cross the blood-brain barrier.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...